Proteasome Inhibition in Myelodysplastic Syndromes and Acute Myelogenous Leukemia Cell Lines

Author： Liesveld Jane L.   Rosell Karen E.   Bechelli Jeremy   Lu Chaohui   Messina Patti   Mulford Deborah   Ifthikharuddin J. J.   Jordan Craig T.   Phillips II Gordon L.  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.29, Iss.7, 2011-07, pp. : 439-450

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Myelodysplastic Syndrome Transforming into Acute Myelogenous Leukemia with Azacytidine: A Retrospective Study from Cancer Centre in Northern India

By Suresh P.  

Indian Journal of Hematology and Blood Transfusion, Vol. 26, Iss. 3, 2010-09 ,pp. : 114-114

Springer Publishing Company

Access to resources Recommend Favorite

Proteasome inhibitors in acute leukemia

By Niewerth Denise   Dingjan Ilse   Cloos Jacqueline   Jansen Gerrit   Kaspers Gertjan  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 327-337

Informa Healthcare

Access to resources Recommend Favorite

miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines

By Gu Jingyi  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 211-218

Humana Press, Inc

Access to resources Recommend Favorite

Somatic mutation of PHF6 gene in T-cell acute lymphoblatic leukemia, acute myelogenous leukemia and hepatocellular carcinoma

By Yoo Nam Jin   Kim Yoo Ri   Lee Sug Hyung  

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 107-111

Informa Healthcare

Access to resources Recommend Favorite

Transformation of Myelodysplastic Syndrome to Acute Lymphoblastic Leukemia in a Child

By Gupta Vineeta  

Indian Journal of Hematology and Blood Transfusion, Vol. 26, Iss. 3, 2010-09 ,pp. : 111-113

Springer Publishing Company

Access to resources Recommend Favorite